Remove Food and Drug Administration Remove Networking Remove Training
article thumbnail

NIH spending for drugs approved 2010-2019 lower than industry spending, study finds

European Pharmaceutical Review

billion for phased clinical trials of US Food and Drug Administration (FDA)-approved drugs between 2010-2019. million publications describing basic or applied research related to 386 of 387 drugs approved 2010-2019 with $8.1 million per approved drug. This was ~10 percent of reported industry spending.

article thumbnail

$8 million grant awarded to new US stem cell clinic

European Pharmaceutical Review

The clinic will develop pre-clinical studies into early and late phase clinical trials to identify US Food and Drug Administration (FDA)-approved advanced regenerative medicines. The organisation considers collaboration will advance scientific discovery, clinical advances and training. Scientific and operational teams.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

ESG Top Trends: Technology trends

Pharmaceutical Technology

AI also speeds up the drug development process, which could translate into cheaper drugs for patients. Aprecia Pharmaceuticals’ Spritam, an anti-epileptic drug, is the first and only 3D-printed pharmaceutical, having received US Food and Drug Administration (FDA) approval in 2015. 3D printing.

article thumbnail

How automation and digital technologies will unlock the full potential of advanced therapies

European Pharmaceutical Review

Training the automation workforce However, the full benefits of these technologies can only be realised if there is a workforce with the specialist skills needed to produce, operate and maintain digital and automation tools. Internet] US Food and Drug Administration. cited 2024Aug]. Available from: [link] 6.

article thumbnail

Why Is FDA Issuing Fewer Marketing Violation Letters?

Pharma Marketing Network

The Food and Drug Administration (FDA) plays a critical role in regulating the pharmaceutical industry and ensuring that medications and medical devices marketed to the public are safe, effective, and appropriately labeled. appeared first on Pharma Marketing Network.

article thumbnail

Amgen commits $8m to clinical trial diversity programme

European Pharmaceutical Review

The Winn Award Program has so far trained 114 early-stage investigator physicians. Currently close to 80 percent of participants in clinical research trials are white, according to the Food and Drug Administration (FDA). Diversity in clinical trials Diversity in clinical trials is a longstanding challenge.

article thumbnail

Hyperfine, Inc. Announces FDA Clearance for Improved AI-Powered Software and Expanded Field of View for the Swoop® Portable MR Imaging® System

Legacy MEDSearch

Food and Drug Administration (FDA) 510(k) clearance and launch of the company’s upgraded AI-powered software. When interpreted by a trained physician, these images provide information that can be useful in determining a diagnosis. Hyperfine, Inc., The Swoop® system received initial U.S.